Trademark Attorney / Law Firm
TAL S. BENSCHAR – Trademark Portfolio
TAL S. BENSCHAR has 5 trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 trademarks are successfully registered — a 60% registration rate. The strongest areas of practice include Class 9 (Computers & Electronics) and Class 5 (Pharmaceuticals). Filing activity has been recorded from 2011 through 2022, spanning 2 years.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
TAL S. BENSCHAR's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademark applications has TAL S. BENSCHAR filed?
TAL S. BENSCHAR has filed 5 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 registered, 1 abandoned, 1 cancelled.
What trademark classes does TAL S. BENSCHAR specialize in?
TAL S. BENSCHAR has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 14 (Jewelry). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
How long has TAL S. BENSCHAR been filing trademarks?
TAL S. BENSCHAR's trademark filing history with the USPTO spans from 2011 to 2022, covering 11 years of trademark practice. During this period, TAL S. BENSCHAR has handled 5 trademark applications.
What is TAL S. BENSCHAR's trademark registration success rate?
TAL S. BENSCHAR has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.